Want to see the rest of our sequencing portfolio? Visit Roche sequencing store!

What is NAVIFY Mutation Profiler?

NAVIFY Mutation Profiler is a clinical NGS reporting workflow solution with a richly curated and up-to-date knowledge base of genetic variants, providing direction through therapy options and clinical trials matching.

Who are the end users of NAVIFY Mutation Profiler?

NAVIFY Mutation Profiler targets clinician molecular pathology labs running NGS tests in-house.

NAVIFY Mutation Profiler is a Clinical Decision Support (CDS) solution used by clinical scientists and pathologists using NGS tests in clinical routine to analyze the variants identified from an NGS test and aids with the interpretation and clinical reporting on the actionable mutations.

Request a free trial of NAVIFY Mutation Profiler. We currently offer you a unique chance to be one of the first to get NAVIFY Mutation Profiler.

Request a free trial

How does NAVIFY Mutation Profiler work? Watch the videos to gain more insights!

NAVIFY Mutation Profiler takes you one step closer to personalized treatment by helping you interpret the clinical significance of mutations whilst decreasing curation time and increasing reproducibility

This is how NAVIFY Mutation Profiler can help you run efficient automated interpretation and reporting for your inhouse NGS solutions.

Download NAVIFY Mutation Profiler curation whitepaper


The 2019 target launch countries for NAVIFY Mutation Profiler are:

  • US
  • Canada
  • UK
  • Germany
  • Austria
  • Netherlands
  • Spain
  • Sweden
  • France

More information on Navify Mutation Profiler